Concepedia

Macrophage Inflammatory Protein-3α Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes

Kai‐Ping Chang, Sheng‐Po Hao, Jui-Hung Chang, Chih‐Ching Wu, Ngan‐Ming Tsang, Yun‐Shien Lee, Chen‐Lung Hsu, Shir‐Hwa Ueng, Shiau-Chin Liu, Yu-Lun Liu,

Clinical Cancer Research · 2008 · 69 citations · 32 references

DOI

Abstract

MIP-3alpha may be a novel biomarker and prognosticator for NPC and is involved in migration and invasion of NPC cells.

References

32

Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma

Jin‐Ching Lin, Wenyi Wang, Kuang Yu Chen et al. · New England Journal of Medicine · 2004 · 913 citations · Full text

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.

Y M Lo, Lisa Chan, Kwok Wai Lo et al. · PubMed · 1999 · 774 citations

, , +16

Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival

Jin‐Ching Lin, Jian‐Sheng Jan, Chen‐Yi Hsu et al. · Journal of Clinical Oncology · 2003 · 768 citations

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure

A. W. Lee, Y.F. Poon, William Foo et al. · International Journal of Radiation Oncology*Biology*Physics · 1992 · 660 citations

, , +8

Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

Gertrude Henle, Werner Henle · International Journal of Cancer · 1976 · 639 citations